SCHEMBL219520

SCHEMBL219520

[CH2]C(=O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL14157181 0.72
SCHEMBL3921147 0.70
SCHEMBL672600 0.70
Bicarbonate SCHEMBL1260607 0.67
SCHEMBL24849 0.67
Glycolic Acid SCHEMBL243061 0.67
Glycolic Acid SCHEMBL1527708 0.67 OR51E2 (0.44)
Glycolic Acid SCHEMBL5315740 0.67 OR51E2 (0.44)
SCHEMBL128661 0.67
SCHEMBL514117 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760708-B2 Compositions and methods for reducing enones to saturated alcohols or ketones YALE UNIVERSITY (US) 2023-09-19 US claimed
CN-112973766-A Preparation method of ammonium bisulfate-resistant flat plate type denitration catalyst and obtained catalyst 大唐南京环保科技有限责任公司 2021-06-18 CN claimed
US-20210163384-A1 Compositions and Methods for Reducing Enones to Saturated Alcohols YALE UNIVERSITY 2021-06-03 US claimed
CN-112645923-A Photoresist resin monomer containing photoacid generator and synthetic method thereof 上海博栋化学科技有限公司 2021-04-13 CN claimed
CN-107496361-B Thyme essential oil solid dispersion and preparation method thereof 浙江工业大学 2020-08-18 CN claimed
CN-109400664-A A kind of extracting method of Rice oil phytosterol 浙江工业大学 2019-03-01 CN claimed
CN-105596306-A Sodium houttuyfonate tablets and preparation method thereof GUANGZHOU YIPINGHONG PHARMACEUTICAL CO LTD 2016-05-25 CN claimed
CN-103417505-B There is huperzine controlled release preparation of two-phase drug release behavior and preparation method thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2016-05-11 CN claimed
EP-2150544-A2 MAPK/ERK KINASE INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2010-02-10 EP claimed
WO-2009146034-A2 MAPK/ERK KINASE INHIBITORS AND METHODS OF USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-03 WO claimed
WO-2008079814-A2 MAPK/ERK KINASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-03 WO claimed
US-20080125437-A1 MAPK/ERK KINASE INHIBITORS TAKEDA SAN DIEGO, INC. 2008-05-29 US claimed
WO-2008055236-A2 MAPK/ERK KINASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-08 WO claimed
EP-1222187-B1 HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF TYROSINE KINASES BOEHRINGER INGELHEIM PHARMA (US) 2004-09-22 EP claimed
US-6770639-B2 CELL PROLIFERATIVE; AUTOIMMUNE DISEASES; ANTIALLERGENS; ANTIINFLAMMATORY AGENTS; ANTICANCER AGENTS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2004-08-03 US claimed
JP-2003527328-A 2003-09-16 JP claimed
US-6506769-B2 Pyridine -imidazole, -thiazole or -oxazole derivatives; treating autoimmune diseases, chronic inflammatory diseases, allergic diseases, transplant rejection and cancer BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2003-01-14 US claimed
EP-1222187-A2 HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF TYROSINE KINASES BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2002-07-17 EP claimed
US-20020016460-A1 Heterocyclic compounds useful as inhibitors of tyrosine kinases BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2002-02-07 US claimed
WO-2001025238-A2 HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF TYROSINE KINASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-04-12 WO claimed